Drug Delivery Systems Market Outlook to 2027: Emerging Trends and Will Generate New Growth Opportunities Status
                     Drug Delivery Systems Market 
Drug Delivery Systems Market to 2027- 
Global Analysis and Forecasts by Route of 
Administration (Oral, Transmucosal, 
Injectable, Topical, Implantable, and 
Ocular); Distribution Channel (Hospital 
Pharmacies, Retail Pharmacies, and Online 
Pharmacies); Application (Hospitals & 
Clinics, Home Care Settings, and Others) 
and Geography
Drug Delivery Systems Market 
Current and future Market Scenario
 According to The Insight Partners market research study titled "Drug Delivery Systems Market - Global Analysis and 
Forecasts by Route of Administration, Application, Distribution Channel, and End User, the global drug delivery systems 
market is expected to reach US$ 2,302.2 Bn in 2027 from US$ 1,243.1 Bn in 2018. The market is estimated to grow with a 
CAGR of 7.2% from 2019-2027. The report highlights the trends prevalent in the global drug delivery systems market and 
the factors driving the market along with those that act as deterrents to its growth.
 The drug delivery systems market by product is segmented into oral, transmucosal, injectable, topical, implantable, and 
ocular. In 2018, oral drug delivery system segment led held a largest market share of 50.2% of the drug delivery systems 
market, by route of administration. Whereas, the transmucosal segment is expected to grow at a CAGR of 8.8% during 
the forecast period from 2019 to 2027. This is primarily attributed to rapidly rising incidence of chronic disorders, 
including gastrointestinal, respiratory, and autoimmune disorders.
 Key factors driving the market are rising incidence of chronic diseases, growing demand for non-invasive drug delivery 
devices, increasing R&D expenditures in and pharmaceutical and medical device companies.
 However, the restraining factors for the market are high cost involved in development of drug delivery devices and 
product recalls.
Key Findings
 The market players are focused towards bringing new and innovative products to sustain their position in the market. 
For instance, in January 2019, BD launched BD Nano 2nd gen pen needles reinforces BD’s commitment to providing the 
most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use. 
The developments performed by the companies are helping the market to grow in the coming years.
Market Insights
Growing Demand for Non-Invasive Drug Delivery Devices to Drive Global Drug Delivery System Market Growth
With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug 
delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. The Non-Invasive 
Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug 
delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular 
membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. 
 
Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain 
involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.
Drug Delivery Systems Market 
 
Market Segments
 
By Route of Administration (Oral, Distribution Channel (Hospital Application (Hospitals & Clinics, 
Transmucosal, Injectable, Topical, Pharmacies, Retail Home Care Settings, and Others)
Implantable, and Ocular) Pharmacies, and Online 
Pharmacies)
Drug Delivery Systems Market 
Dominating Segments
 
 Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug 
  delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, 
implantable, and ocular among others. 
 Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various 
therapeutic agents to treat various diseases or improve the health of the patients. 
 The growth of the global drug delivery system market is attributed to the rising incidence of chronic diseases, 
growing demand for non-invasive drug delivery devices, and increasing R&D expenditure in pharmaceutical 
and medical devices. However, high cost involved in development of drug delivery systems and product 
recalls are the major factor hindering the market growth.
Dominating Segments
Product Insights
Route of Administration -Based Insights
 In terms of route of administration, the global drug delivery system market is segmented into oral, transmucosal, 
topical, injectable, implantable and ocular drug delivery. In 2018, the oral segment held largest share of the 
market. However, the transmucosal segment is estimated to register the highest CAGR during the forecast period.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPHE100000854/ 
Dominating Segments
The report segments the global Drug Delivery Systems market as follows:
 
Global Drug Delivery System Market – by Route of Administration
Oral
Transmucosal
Injectable
Topical
Implantable
Ocular
Dominating Segments
Global Drug Delivery System Market – by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Drug Delivery System Market – by Application
Hospital & Clinics
Home Care Settings
Others
Drug Delivery Systems Market  
Leading Players
Company Profiles in Drug Delivery Systems Market are:
BD
Novo Nordisk A/S
3M
Boston Scientific Corporation
Bausch Health Companies Inc.
Baxter International, Inc.,
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
 
 Drug Delivery Systems Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/drug-delivery-devices-market
 
Thank You! 
Thank You!